title: [Is the risk of pneumocystosis predictable in Wegener's disease?].
abstract: Twelve cases of Pneumocystis pneumonia in patients with Wegener's granulomatosis were compared with a control-group of 32 patients. Our study showed that the dose of cyclophosphamide received in the first three months and a profound lymphocytopenia were strongly predictive of a risk of Pneumocystis carinii pneumonia in these patients.
authors.affiliation: Service de médecine interne I, hôpital Henri Mondor, Créteil.
authors.forename: B
authors.initials: B
authors.lastname: Godeau
authors.forename: J L
authors.initials: JL
authors.lastname: Mainardi
authors.forename: E
authors.initials: E
authors.lastname: Hachulla
authors.forename: L
authors.initials: L
authors.lastname: Guillevin
authors.forename: F
authors.initials: F
authors.lastname: Roudot-Thoraval
authors.forename: P
authors.initials: P
authors.lastname: Remy
authors.forename: L T
authors.initials: LT
authors.lastname: Huong-Boutin
authors.forename: A
authors.initials: A
authors.lastname: Schaeffer
authors.forename: J C
authors.initials: JC
authors.lastname: Piette
mesh_terms: D003520:Cyclophosphamide / Q000009:adverse effects; D014890:Granulomatosis with Polyangiitis / Q000150:complications*; D006801:Humans; D008231:Lymphopenia / Q000139:chemically induced; D011020:Pneumonia, Pneumocystis / Q000209:etiology* / Q000517:prevention & control; D012189:Retrospective Studies; D012307:Risk Factors
chemical_list: D003520:Cyclophosphamide
vernacular_title: Le risque de pneumocystose est-il prévisible au cours de la maladie de Wegener?